Hypoxia, gene expression, and metastasis

Cancer and Metastasis Reviews

Volumn 26, Issue 2, 2007, Pages 333-339

  Chan, Denise A ^a   Giaccia, Amato J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Chemotherapy; Hypoxia; Hypoxia inducible factor; Metastasis; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CXCR4; CONNECTIVE TISSUE GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MIGRATION INHIBITION FACTOR; PROTEIN LYSINE 6 OXIDASE; UVOMORULIN;

CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CELL AGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE INTERACTION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HYPOXIA; METASTASIS; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR VASCULARIZATION;

CELL DIVISION; CELL HYPOXIA; CELL MOVEMENT; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 34547125574     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-007-9063-1     Document Type: Review

References (60)

1. Brown, J. M., & Giaccia, A. J. (1998). The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Research, 58, 1408-1416.
2. Hockel, M., Schlenger, K., Knoop, C., & Vaupel, P. (1991). Oxygenation of carcinomas of the uterine cervix: Evaluation by computerized O2 tension measurements. Cancer Research, 51, 6098-6102.
3. Folkman, J. (1992). The role of angiogenesis in tumor growth. Seminars in Cancer Biology, 3, 65-71.
4. Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359, 843-845.
5. Grunt, T. W., Lametschwandtner, A., & Staindl, O. (1985). The vascular pattern of basal cell tumors: Light microscopy and scanning electron microscopic study on vascular corrosion casts. Microvascular Research, 29, 371-386.
6. Dewhirst, M. W., Tso, C. Y., Oliver, R., Gustafson, C. S., Secomb, T. W., & Gross, J. F. (1989). Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. International Journal of Radiation Oncology, Biology, Physics, 17, 91-99.
7. Shah-Yukich, A. A., & Nelson, A. C. (1988). Characterization of solid tumor microvasculature: A three-dimensional analysis using the polymer casting technique. Laboratory Investigation, 58, 236-244.
8. Endrich, B., Reinhold, H. S., Gross, J. F., & Intaglietta, M. (1979). Tissue perfusion inhomogeneity during early tumor growth in rats. Journal of the National Cancer Institute, 62, 387-395.
9. Tannock, I. F. (1968). The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. British Journal of Cancer, 22, 258-273.
10. Kallman, R. F., & Dorie, M. J. (1986). Tumor oxygenation and reoxygenation during radiation therapy: Their importance in predicting tumor response. International Journal of Radiation Oncology, Biology, Physics, 12, 681-685.
11. Hall, E. J. (1994). Molecular biology in radiation therapy: The potential impact of recombinant technology on clinical practice. International Journal of Radiation Oncology, Biology, Physics, 30, 1019-1028.
12. Comerford, K. M., Wallace, T. J., Karhausen, J., Louis, N. A., Montalto, M. C., & Colgan, S. P. (2002). Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Research, 62, 3387-3394.
13. Wartenberg, M., Ling, F. C., Muschen, M., Klein, F., Acker, H., Gassmann, M., et al. (2003). Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB Journal, 17, 503-505.
14. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., et al. (1996). Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.
15. Soengas, M. S., Alarcon, R. M., Yoshida, H., Giaccia, A. J., Hakem, R., Mak, T. W., et al. (1999). Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science, 284, 156-159.
16. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., et al. (1994). p53 status and the efficacy of cancer therapy in vivo. Science, 266, 807-810.
17. Bindra, R. S., & Glazer, P. M. (2005). Genetic instability and the tumor microenvironment: Towards the concept of microenvironment-induced mutagenesis. Mutation Research, 569, 75-85.
18. Bindra, R. S., & Glazer, P. M. (2007). Co-repression of mismatch repair gene expression by hypoxia in cancer cells: Role of the Myc/Max network. Cancer Letter (in press).
19. Huang, L. E., Bindra, R. S., Glazer, P. M., & Harris, A. L. (2007). Hypoxia-induced genetic instability-a calculated mechanism underlying tumor progression. Journal of Molecular Medicine, 85, 139-148.
20. Koshiji, M., To, K. K., Hammer, S., Kumamoto, K., Harris, A. L., Modrich, P., et al. (2005). HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Molecular Cell, 17, 793-803.
21. Hockel, M., Knoop, C., Schlenger, K., Vorndran, B., Baussmann, E., Mitze, M., et al. (1993). Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiotherapy and Oncology, 26, 45-50.
22. Brizel, D. M., Scully, S. P., Harrelson, J. M., Layfield, L. J., Bean, J. M., Prosnitz, L. R., et al. (1996). Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Research, 56, 941-943.
23. Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., & Vaupel, P. (1996). Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Research, 56, 4509-4515.
24. Fyles, A. W., Milosevic, M., Wong, R., Kavanagh, M. C., Pintilie, M., Sun, A., et al. (1998). Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiotherapy and Oncology, 48, 149-156.
25. Nordsmark, M., Hoyer, M., Keller, J., Nielsen, O. S., Jensen, O. M., & Overgaard, J. (1996). The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. International Journal of Radiation Oncology, Biology, Physics, 35, 701-708.
26. Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., et al. (2001). HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science, 292, 464-468.
27. Jaakkola, P., Mole, D. R., Tian, Y. M., Wilson, M. I., Gielbert, J., Gaskell, S. J., et al. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 292, 468-472.
28. Yu, F., White, S. B., Zhao, Q., & Lee, F. S. (2001). HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proceedings of the National Academy of Sciences of the USA, 98, 9630-9635.
29. Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998). Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proceedings of the National Academy of Sciences of the USA, 95, 7987-7992.
30. Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001). Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO Journal, 20, 5197-5206.
31. Chan, D. A., Sutphin, P. D., Denko, N. C., & Giaccia, A. J. (2002). Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. Journal of Biological Chemistry, 277, 40112-40117.
32. Chan, D. A., Sutphin, P. D., Yen, S. E., & Giaccia, A. J. (2005). Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Molecular and Cellular Biology, 25, 6415-6426.
33. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell, 107, 43-54.
34. Bruick, R. K., & McKnight, S. L. (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 294, 1337-1340.
35. Semenza, G. L. (1999). Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annual Review of Cell and Development Biology, 15, 551-578.
36. Hickey, M. M., & Simon, M. C. (2006). Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Current Topics in Developmental Biology, 76, 217-257.
37. Brahimi-Horn, M. C., & Pouyssegur, J. (2007). Harnessing the hypoxia-inducible factor in cancer and ischemic disease. Biochemical Pharmacology, 73, 450-457.
38. Denko, N. C., Fontana, L. A., Hudson, K. M., Sutphin, P. D., Raychaudhuri, S., Altman, R., et al. (2003). Investigating hypoxic tumor physiology through gene expression patterns. Oncogene, 22, 5907-5914.
39. Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhofer, N., Kong, C., Le, Q. T., et al. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature, 440, 1222-1226.
40. Erler, J. T., & Giaccia, A. J. (2006). Lysyl oxidase mediates hypoxic control of metastasis. Cancer Research, 66, 10238-10241.
41. Higgins, D. F., Biju, M. P., Akai, Y., Wutz, A., Johnson, R. S., & Haase, V. H. (2004). Hypoxic induction of Ctgf is directly mediated by Hif-1. American Journal of Physiology. Renal Physiology, 287, F1223-F1232.
42. Wenger, C., Ellenrieder, V., Alber, B., Lacher, U., Menke, A., Hameister, H., et al. (1999). Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene, 18, 1073-1080.
43. Dornhofer, N., Spong, S., Bennewith, K., Salim, A., Klaus, S., Kambham, N., et al. (2006). Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Research, 66, 5816-5827.
44. Aikawa, T., Gunn, J., Spong, S. M., Klaus, S. J., & Korc, M. (2006). Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Molecular Cancer Therapeutic, 5, 1108-1116.
45. Krishnamachary, B., Zagzag, D., Nagasawa, H., Rainey, K., Okuyama, H., Baek, J. H., et al. (2006). Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Research, 66, 2725-2731.
46. Esteban, M. A., Tran, M. G., Harten, S. K., Hill, P., Castellanos, M. C., Chandra, A., et al. (2006). Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Research, 66, 3567-3575.
47. Evans, A. J., Russell, R. C., Roche, O., Burry, T. N., Fish, J. E., Chow, V. W., et al. (2007). VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Molecular and Cellular Biology, 27, 157-169.
48. Wang, J., Loberg, R., & Taichman, R. S. (2006). The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Reviews, 25, 573-587.
49. Pore, N., & Maity, A. (2006). The Chemokine Receptor CXCR4: A Homing Device for Hypoxic Cancer Cells? Cancer Biology and Therapy, 5, 1563-1565.
50. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-56.
51. Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003). Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature, 425, 307-311.
52. Cooper, C. R., Sikes, R. A., Nicholson, B. E., Sun, Y. X., Pienta, K. J., & Taichman, R. S. (2004). Cancer cells homing to bone: the significance of chemotaxis and cell adhesion. Cancer Treatment and Research, 118, 291-309.
53. Taichman, R. S., Cooper, C., Keller, E. T., Pienta, K. J., Taichman, N. S., & McCauley, L. K. (2002). Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Research, 62, 1832-1837.
54. Robledo, M. M., Bartolome, R. A., Longo, N., Rodriguez-Frade, J. M., Mellado, M., Longo, I., et al. (2001). Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. Journal of Biological Chemistry, 276, 45098-45105.
55. Scala, S., Ottaiano, A., Ascierto, P. A., Cavalli, M., Simeone, E., Giuliano, P., et al. (2005). Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clinical Cancer Research, 11, 1835-1841.
56. Longo-Imedio, M. I., Longo, N., Trevino, I., Lazaro, P., & Sanchez-Mateos, P. (2005). Clinical significance of CXCR3 and CXCR4 expression in primary melanoma. International Journal of Cancer, 117, 861-865.
57. Scala, S., Giuliano, P., Ascierto, P. A., Ierano, C., Franco, R., Napolitano, M., et al. (2006). Human melanoma metastases express functional CXCR4. Clinical Cancer Research, 12, 2427-2433.
58. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Medicine, 10, 858-864.
59. Welford, S. M., Bedogni, B., Gradin, K., Poellinger, L., Broome Powell, M., & Giaccia, A. J. (2006). HIF1alpha delays premature senescence through the activation of MIF. Genes & Development, 20, 3366-3371.
60. Lal, A., Peters, H., St Croix, B., Haroon, Z. A., Dewhirst, M. W., Strausberg, R. L., et al. (2001). Transcriptional response to hypoxia in human tumors. Journal of the National Cancer Institute, 93, 1337-1343.